Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2009 | 1 |
2010 | 2 |
2011 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
A randomized clinical trial evaluating therapeutic drug monitoring (TDM) for protease inhibitor-based regimens in antiretroviral-experienced HIV-infected individuals: week 48 results of the A5146 study.
HIV Clin Trials. 2011 Jul-Aug;12(4):201-14. doi: 10.1310/hct1204-201.
HIV Clin Trials. 2011.
PMID: 22044856
Free PMC article.
Clinical Trial.
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
Wilkin TJ, Su Z, Krambrink A, Long J, Greaves W, Gross R, Hughes MD, Flexner C, Skolnik PR, Coakley E, Godfrey C, Hirsch M, Kuritzkes DR, Gulick RM.
Wilkin TJ, et al.
J Acquir Immune Defic Syndr. 2010 Aug;54(5):470-6. doi: 10.1097/qai.0b013e3181e2cba0.
J Acquir Immune Defic Syndr. 2010.
PMID: 20672447
Free PMC article.
Clinical Trial.
Item in Clipboard
Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211.
Yeh TM, Evans SR, Gulick RM, Clifford DB.
Yeh TM, et al.
HIV Clin Trials. 2010 Jan-Feb;11(1):51-8. doi: 10.1310/hct1101-51.
HIV Clin Trials. 2010.
PMID: 20400411
Free PMC article.
Clinical Trial.
Item in Clipboard
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patients.
Demeter LM, Jiang H, Mukherjee AL, Morse GD, DiFrancesco R, DiCenzo R, Dykes C, Sista P, Bacheler L, Klingman K, Rinehart A, Albrecht M.
Demeter LM, et al.
AIDS. 2009 Jan 28;23(3):357-68. doi: 10.1097/QAD.0b013e32831f9148.
AIDS. 2009.
PMID: 19114860
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
Gulick RM, Su Z, Flexner C, Hughes MD, Skolnik PR, Wilkin TJ, Gross R, Krambrink A, Coakley E, Greaves WL, Zolopa A, Reichman R, Godfrey C, Hirsch M, Kuritzkes DR; AIDS Clinical Trials Group 5211 Team.
Gulick RM, et al.
J Infect Dis. 2007 Jul 15;196(2):304-12. doi: 10.1086/518797. Epub 2007 Jun 5.
J Infect Dis. 2007.
PMID: 17570119
Clinical Trial.
Item in Clipboard
Cite
Cite